Qualitative and Quantitative Evaluation of the BCR-ABL Fusion Gene in Chronic Myelogenous Leukemia by Flourescence In Situ Hybridization and Molecular …

S Ozemri Sag, T Yakut, O Gorukmez… - Genetic testing and …, 2015 - liebertpub.com
Aims: Fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …

Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic …

T Yakut, O Gorukmez, M Ture, M Karkucak… - Genetic Testing and …, 2015 - europepmc.org
Aims Fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …

Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic …

SO Sag, T Yakut, O Gorukmez… - Genetic testing and …, 2015 - pubmed.ncbi.nlm.nih.gov
Aims Fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …

Qualitative and Quantitative Evaluation of the BCR-ABL Fusion Gene in Chronic Myelogenous Leukemia by Flourescence In Situ Hybridization and Molecular Genetic …

Ş ÖZEMRİ SAĞ, T Yakut, O Gorukmez… - GENETIC TESTING …, 2015 - avesis.uludag.edu.tr
Aims: Fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …